Next Article in Journal
Detection of Functional Overreaching in Endurance Athletes Using Proteomics
Next Article in Special Issue
Granulocyte-Colony-Stimulating Factor Alters the Proteomic Landscape of the Ventral Tegmental Area
Previous Article in Journal / Special Issue
Regional Diversity in the Postsynaptic Proteome of the Mouse Brain
Article Menu

Export Article

Open AccessFeature PaperReview
Proteomes 2018, 6(3), 32; https://doi.org/10.3390/proteomes6030032

Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias

Massachusetts General Hospital Department of Neurology, Charlestown, MA 02129, USA
*
Author to whom correspondence should be addressed.
Received: 20 July 2018 / Revised: 22 August 2018 / Accepted: 29 August 2018 / Published: 31 August 2018
(This article belongs to the Special Issue Neuroproteomics)
Full-Text   |   PDF [726 KB, uploaded 31 August 2018]   |  

Abstract

Neurodegenerative dementias are highly complex disorders driven by vicious cycles of intersecting pathophysiologies. While most can be definitively diagnosed by the presence of disease-specific pathology in the brain at postmortem examination, clinical disease presentations often involve substantially overlapping cognitive, behavioral, and functional impairment profiles that hamper accurate diagnosis of the specific disease. As global demographics shift towards an aging population in developed countries, clinicians need more sensitive and specific diagnostic tools to appropriately diagnose, monitor, and treat neurodegenerative conditions. This review is intended as an overview of how modern proteomic techniques (liquid chromatography mass spectrometry (LC-MS/MS) and advanced capture-based technologies) may contribute to the discovery and establishment of better biofluid biomarkers for neurodegenerative disease, and the limitations of these techniques. The review highlights some of the more interesting technical innovations and common themes in the field but is not intended to be an exhaustive systematic review of studies to date. Finally, we discuss clear reporting principles that should be integrated into all studies going forward to ensure data is presented in sufficient detail to allow meaningful comparisons across studies. View Full-Text
Keywords: neurodegeneration; Alzheimer’s disease; cerebrospinal fluid; plasma; serum; proteomics; biomarkers; LC-MS/MS neurodegeneration; Alzheimer’s disease; cerebrospinal fluid; plasma; serum; proteomics; biomarkers; LC-MS/MS
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Carlyle, B.C.; Trombetta, B.A.; Arnold, S.E. Proteomic Approaches for the Discovery of Biofluid Biomarkers of Neurodegenerative Dementias. Proteomes 2018, 6, 32.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Proteomes EISSN 2227-7382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top